EHC
Encompass Health Corporation NYSE Listed Sep 24, 1986$107.16
Mkt Cap $10.6B
52w Low $92.77
40.9% of range
52w High $127.99
50d MA $103.23
200d MA $111.40
P/E (TTM)
19.1x
EV/EBITDA
9.5x
P/B
3.3x
Debt/Equity
1.1x
ROE
23.2%
P/FCF
24.3x
RSI (14)
—
ATR (14)
—
Beta
0.60
50d MA
$103.23
200d MA
$111.40
Avg Volume
1.1M
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
9001 Liberty Parkway · Birmingham, AL 35242 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 1.51 | 1.60 | +6.0% | 100.00 | +1.4% | +7.5% | -0.8% | -1.4% | -0.1% | +2.0% | — |
| Feb 5, 2026 | AMC | 1.29 | 1.46 | +13.2% | 99.56 | +15.5% | +5.9% | +0.7% | +2.7% | +4.1% | -1.2% | — |
| Oct 29, 2025 | AMC | 1.19 | 1.23 | +3.4% | 125.63 | -9.9% | -7.0% | -2.5% | +1.9% | +0.9% | -1.6% | — |
| Aug 4, 2025 | AMC | 1.23 | 1.40 | +13.8% | 109.50 | +1.9% | +4.0% | +2.3% | +0.0% | +0.9% | -0.1% | — |
| Apr 24, 2025 | AMC | 1.19 | 1.37 | +15.1% | 101.41 | +9.9% | +11.8% | +1.7% | +0.5% | +0.9% | -0.9% | — |
| Feb 6, 2025 | AMC | 1.05 | 1.17 | +11.4% | 98.60 | +3.8% | +1.3% | -1.2% | +0.8% | -1.4% | +2.2% | — |
| Oct 28, 2024 | AMC | 0.94 | 1.03 | +9.6% | 93.09 | +8.0% | +7.4% | +1.3% | -1.9% | -0.6% | +1.3% | — |
| Aug 5, 2024 | AMC | 1.01 | 1.11 | +9.9% | 89.67 | -3.9% | -5.6% | +0.4% | +2.5% | -1.6% | +1.3% | — |
| Apr 24, 2024 | AMC | 0.94 | 1.12 | +19.1% | 82.80 | +3.0% | -0.1% | -0.3% | +1.4% | -0.3% | -0.6% | — |
| Feb 7, 2024 | AMC | 0.82 | 0.95 | +15.9% | 72.76 | +1.0% | +0.9% | -0.7% | +0.9% | -0.7% | +0.4% | — |
| Oct 26, 2023 | AMC | 0.77 | 0.86 | +11.7% | 61.23 | +2.8% | -0.6% | -0.4% | +3.2% | +0.0% | +1.1% | — |
| Aug 1, 2023 | AMC | 0.75 | 0.95 | +26.7% | 65.96 | +3.8% | +5.1% | +1.8% | -0.5% | +2.0% | -0.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6 | Barclays | Maintains | Overweight → Overweight | — | $99.56 | $115.00 | +15.5% | +5.9% | +0.7% | +2.7% | +4.1% | -1.2% |
| Oct 30 | Barclays | Maintains | Overweight → Overweight | — | $125.63 | $113.18 | -9.9% | -7.0% | -2.5% | +1.9% | +0.9% | -1.6% |
| Oct 2 | UBS | Maintains | Buy → Buy | — | $124.52 | $125.00 | +0.4% | -0.8% | -0.3% | +0.3% | +1.3% | -0.6% |
| Sep 16 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $124.66 | $124.88 | +0.2% | -0.7% | +0.4% | +0.8% | -1.0% | +1.6% |
| Sep 10 | BofA Securities | Maintains | Buy → Buy | — | $125.29 | $125.24 | -0.0% | -0.6% | +1.8% | -0.6% | -1.1% | -0.7% |
| Aug 14 | Truist | Maintains | Buy → Buy | — | $119.13 | $119.30 | +0.1% | +0.4% | +0.6% | -0.1% | +1.6% | +1.1% |
| Aug 6 | UBS | Maintains | Buy → Buy | — | $113.88 | $114.43 | +0.5% | +2.3% | +0.0% | +0.9% | -0.1% | +1.0% |
| Jun 5 | Stephens & Co. | Maintains | Overweight → Overweight | — | $121.27 | $121.81 | +0.4% | +0.0% | +0.2% | -1.0% | -0.9% | +0.2% |
| May 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $118.90 | $119.74 | +0.7% | +1.8% | -1.2% | +0.4% | +0.7% | -0.0% |
| Apr 28 | RBC Capital | Maintains | Outperform → Outperform | — | $113.37 | $113.44 | +0.1% | +1.7% | +0.5% | +0.9% | -0.9% | +0.6% |
| Apr 28 | Truist | Maintains | Buy → Buy | — | $113.37 | $113.44 | +0.1% | +1.7% | +0.5% | +0.9% | -0.9% | +0.6% |
| Apr 28 | UBS | Maintains | Buy → Buy | — | $113.37 | $113.44 | +0.1% | +1.7% | +0.5% | +0.9% | -0.9% | +0.6% |
| Apr 25 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $101.41 | $111.45 | +9.9% | +11.8% | +1.7% | +0.5% | +0.9% | -0.9% |
| Apr 25 | Barclays | Maintains | Overweight → Overweight | — | $101.41 | $111.45 | +9.9% | +11.8% | +1.7% | +0.5% | +0.9% | -0.9% |
| Feb 11 | RBC Capital | Maintains | Outperform → Outperform | — | $98.63 | $98.84 | +0.2% | +0.8% | -1.4% | +2.2% | +0.7% | +1.3% |
| Feb 10 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $99.86 | $99.23 | -0.6% | -1.2% | +0.8% | -1.4% | +2.2% | +0.7% |
| Feb 7 | Barclays | Maintains | Overweight → Overweight | — | $98.60 | $102.36 | +3.8% | +1.3% | -1.2% | +0.8% | -1.4% | +2.2% |
| Oct 30 | Truist | Maintains | Buy → Buy | — | $100.00 | $99.78 | -0.2% | +1.3% | -1.9% | -0.6% | +1.3% | +1.1% |
| Oct 30 | RBC Capital | Maintains | Outperform → Outperform | — | $100.00 | $99.78 | -0.2% | +1.3% | -1.9% | -0.6% | +1.3% | +1.1% |
| Oct 29 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $93.09 | $100.50 | +8.0% | +7.4% | +1.3% | -1.9% | -0.6% | +1.3% |
| Oct 29 | Barclays | Maintains | Overweight → Overweight | — | $93.09 | $100.50 | +8.0% | +7.4% | +1.3% | -1.9% | -0.6% | +1.3% |
| Oct 14 | Truist | Maintains | Buy → Buy | — | $95.97 | $96.05 | +0.1% | +0.3% | +0.0% | +1.1% | -0.5% | +0.3% |
| Sep 26 | RBC Capital | Maintains | Outperform → Outperform | — | $96.75 | $96.84 | +0.1% | +0.4% | -1.2% | +0.7% | -0.9% | -0.7% |
| Sep 25 | UBS | Maintains | Buy → Buy | — | $95.26 | $95.80 | +0.6% | +1.6% | +0.4% | -1.2% | +0.7% | -0.9% |
| Aug 15 | Truist | Maintains | Buy → Buy | — | $86.98 | $88.26 | +1.5% | +2.7% | -0.8% | -0.0% | +0.0% | +0.9% |
| Aug 8 | UBS | Maintains | Buy → Buy | — | $84.99 | $85.21 | +0.3% | +2.5% | -1.6% | +1.3% | +0.2% | -0.0% |
| Aug 6 | Stephens & Co. | Maintains | Overweight → Overweight | — | $89.67 | $86.14 | -3.9% | -5.6% | +0.4% | +2.5% | -1.6% | +1.3% |
| Aug 6 | Barclays | Maintains | Overweight → Overweight | — | $89.67 | $86.14 | -3.9% | -5.6% | +0.4% | +2.5% | -1.6% | +1.3% |
| Jul 15 | Truist | Maintains | Buy → Buy | — | $86.54 | $86.31 | -0.3% | -1.2% | +1.9% | -0.3% | -1.8% | +0.1% |
| Jul 10 | Barclays | Maintains | Overweight → Overweight | — | $83.97 | $84.45 | +0.6% | +1.0% | +1.3% | +0.7% | -1.2% | +1.9% |
| Jun 5 | Stephens & Co. | Maintains | Overweight → Overweight | — | $84.50 | $84.71 | +0.2% | +1.8% | -0.9% | -0.5% | +1.3% | -1.6% |
| May 22 | RBC Capital | Maintains | Outperform → Outperform | — | $85.80 | $85.71 | -0.1% | -0.5% | -0.9% | -0.1% | -1.2% | +0.9% |
| Apr 26 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $82.73 | $82.32 | -0.5% | -0.3% | +1.4% | -0.3% | -0.6% | +0.7% |
| Apr 25 | Barclays | Maintains | Overweight → Overweight | — | $82.80 | $85.25 | +3.0% | -0.1% | -0.3% | +1.4% | -0.3% | -0.6% |
| Apr 25 | Mizuho | Maintains | Buy → Buy | — | $82.80 | $85.25 | +3.0% | -0.1% | -0.3% | +1.4% | -0.3% | -0.6% |
| Mar 28 | Barclays | Maintains | Overweight → Overweight | — | $77.71 | $80.19 | +3.2% | +6.3% | +0.8% | -1.5% | +0.2% | -1.5% |
| Feb 9 | Mizuho | Maintains | Buy → Buy | — | $73.45 | $74.17 | +1.0% | -0.7% | +0.9% | -0.7% | +0.4% | +0.6% |
| Feb 9 | Truist | Maintains | Buy → Buy | — | $73.45 | $74.17 | +1.0% | -0.7% | +0.9% | -0.7% | +0.4% | +0.6% |
| Feb 9 | RBC Capital | Maintains | Outperform → Outperform | — | $73.45 | $74.17 | +1.0% | -0.7% | +0.9% | -0.7% | +0.4% | +0.6% |
| Jan 16 | Stephens & Co. | Maintains | Overweight → Overweight | — | $68.94 | $68.74 | -0.3% | +3.6% | -2.3% | +1.5% | -0.6% | +0.7% |
| Sep 28 | RBC Capital | Maintains | Outperform → Outperform | — | $67.11 | $67.56 | +0.7% | +0.7% | -0.6% | -0.8% | -1.1% | +0.7% |
| Aug 8 | RBC Capital | Maintains | Outperform → Outperform | — | $71.67 | $71.82 | +0.2% | -0.4% | -1.0% | -0.1% | +0.7% | +1.0% |
| Aug 4 | Credit Suisse | Maintains | Outperform → Outperform | — | $70.58 | $70.65 | +0.1% | -0.5% | +2.0% | -0.4% | -1.0% | -0.1% |
| Aug 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $70.58 | $70.65 | +0.1% | -0.5% | +2.0% | -0.4% | -1.0% | -0.1% |
| Aug 3 | Truist | Maintains | Buy → Buy | — | $69.32 | $69.56 | +0.3% | +1.8% | -0.5% | +2.0% | -0.4% | -1.0% |
| Aug 3 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $69.32 | $69.56 | +0.3% | +1.8% | -0.5% | +2.0% | -0.4% | -1.0% |
| Aug 3 | Mizuho | Maintains | Buy → Buy | — | $69.32 | $69.56 | +0.3% | +1.8% | -0.5% | +2.0% | -0.4% | -1.0% |
| Aug 3 | Barclays | Maintains | Equal Weight → Equal Weight | — | $69.32 | $69.56 | +0.3% | +1.8% | -0.5% | +2.0% | -0.4% | -1.0% |
| Jul 20 | Stephens & Co. | Maintains | Overweight → Overweight | — | $68.35 | $68.87 | +0.8% | +0.3% | -2.9% | +0.3% | +1.4% | -2.4% |
| Jun 29 | Stephens & Co. | Maintains | Overweight → Overweight | — | $66.85 | $67.33 | +0.7% | +0.3% | +1.0% | -0.8% | -0.5% | -1.7% |
No insider trades available.
8-K
Unknown — 8-K Filing
The merger is progressing on schedule with regulatory approval secured, suggesting the deal will close in Q2 2026 as planned, reducing execution risk for shareholders awaiting the transaction completion.
Apr 16
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
EHC terminated its credit facility with Barclays, signaling either refinancing with better terms or reduced borrowing needs, which could improve financial flexibility and reduce debt costs going forward.
Mar 10
8-K · 5.02
!!! Very High
Encompass Health Corporation -- 8-K 5.02: Executive Change
Encompass Health Corporation appointed a new director, Mr. Hayes, signaling potential strategic shifts or governance changes that investors should monitor for impact on company direction.
Feb 20
8-K · 5.02
!!! Very High
Norwegian Cruise Line Holdings Ltd. -- 8-K 5.02: Executive Change
Norwegian Cruise Line Holdings appointed John W. Chidsey as President, a leadership change that may signal strategic direction shifts for the cruise operator's operational and growth initiatives.
Feb 12
8-K · 5.02
!!! Very High
NCL CORP Ltd. -- 8-K 5.02: Executive Change
Norwegian Cruise Line Holdings appointed John W. Chidsey as President, signaling potential strategic leadership changes that investors should monitor for operational and financial direction shifts.
Feb 12
8-K · 7.01
! Medium
Encompass Health Corporation -- 8-K 7.01: Regulation FD Disclosure
Encompass Health disclosed non-material information under Regulation FD that won't be legally incorporated into SEC filings unless explicitly referenced elsewhere.
Feb 5
8-K · 5.02
!!! Very High
Encompass Health Corporation -- 8-K 5.02: Executive Change
Encompass Health Corporation appointed Cain A. Hayes as a director, adding new board representation that could influence governance and strategic decisions for the healthcare services provider.
Feb 2
Data updated apr 25, 2026 6:42am
· Source: massive.com